Rami Elghandour, Arcellx CEO
Arcellx, Kite aim to keep chipping away at Carvykti advantage with new multiple myeloma data: #ASH23
SAN DIEGO — Arcellx raised the curtain on the CAR-T data it will present on Monday at the American Society of Hematology conference as it readies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
